Metabolic Adaptation Strategies in Cancer Cell Nutrition

Cancer cells reprogramme their metabolic circuits to support sustained proliferation within the often hostile tumour microenvironment. Beyond the classical reliance on aerobic glycolysis, malignant cells exploit a suite of adaptive strategies to secure energy and biosynthetic precursors. These include enhanced macropinocytosis for uptake of extracellular proteins and lipids, autophagy-mediated recycling of intracellular components, upregulation of membrane transporters for glucose and amino acids, and activation of alternative nutrient-scavenging pathways under hypoxia or nutrient deprivation. Collectively, these mechanisms confer metabolic plasticity, enabling tumours to maintain redox balance, fuel anabolic growth and resist therapeutic stress. Understanding the interplay between these routes offers avenues for novel interventions that selectively starve cancer cells while sparing normal tissues.

Research from Nature Portfolio

Recent studies have elucidated how macropinocytosis not only supplies amino acids but also delivers sugars, fatty acids and nucleotides to fuel biosynthesis and confer resistance to therapies targeting anabolic pathways. In models of breast, pancreas and prostate cancer, scavenging of necrotic debris via macropinocytosis was shown to sustain proliferation despite inhibition of fatty acid synthase or nucleotide biosynthesis, and genetic blockade of this process restored drug sensitivity in vivo. Another line of work has revealed that hypoxia in hepatocellular carcinoma activates a transcriptional programme driven by HIF-1 that upregulates the membrane-dynamics protein EHD2, triggering macropinocytosis. Suppression of either HIF-1 or EHD2 abrogated protein scavenging under low-oxygen conditions and impeded tumour growth in mouse models, highlighting macropinocytosis as a key survival route in hypoxic solid tumours.

Metabolic Adaptation Strategies in Cancer Cell Nutrition publication trend

The graph below shows the total number of articles in metabolic adaptation strategies in cancer cell nutrition across all publications each year (not limited to Nature Index journals).

Technical terms

Macropinocytosis: A non-selective endocytic process by which large vesicles engulf extracellular fluid and macromolecules for lysosomal degradation and nutrient recovery.

Autophagy: The lysosome-mediated recycling pathway that degrades intracellular organelles and proteins to supply metabolic precursors under stress.

Warburg effect: The propensity of cancer cells to favour glycolysis over oxidative phosphorylation for energy production, even in the presence of oxygen.

Hypoxia-inducible factor (HIF-1): A transcription factor stabilised by low oxygen that orchestrates gene expression programmes for metabolic adaptation in tumours.

Ubiquitin–proteasome system: A protein degradation pathway that tags and breaks down intracellular proteins, contributing to amino acid pools under nutrient limitation.

References

1. Amino Acid‐Starved Cancer Cells Utilize Macropinocytosis and Ubiquitin‐Proteasome System for Nutrient Acquisition. Advanced Science (2023).
2. Recent progress in the development of nanomaterials targeting multiple cancer metabolic pathways: a review of mechanistic approaches for cancer treatment. Drug Delivery (2023).
3. Macropinocytosis confers resistance to therapies targeting cancer anabolism. Nature Communications (2020).
4. Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer. Nature Communications (2022).
5. The phospholipid flippase ATP9A enhances macropinocytosis to promote nutrient starvation tolerance in hepatocellular carcinoma. The Journal of Pathology (2023).